Cencora, Inc. $COR Position Lifted by Graham Capital Management L.P.

Graham Capital Management L.P. raised its stake in shares of Cencora, Inc. (NYSE:COR) by 95.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 21,715 shares of the company’s stock after acquiring an additional 10,615 shares during the quarter. Graham Capital Management L.P.’s holdings in Cencora were worth $7,334,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in COR. AustralianSuper Pty Ltd acquired a new stake in shares of Cencora during the third quarter worth $26,191,000. Lansforsakringar Fondforvaltning AB publ raised its holdings in shares of Cencora by 5.4% during the third quarter. Lansforsakringar Fondforvaltning AB publ now owns 60,254 shares of the company’s stock worth $18,831,000 after purchasing an additional 3,073 shares during the period. Chilton Investment Co. Inc. acquired a new stake in shares of Cencora during the third quarter worth $459,000. Nordea Investment Management AB raised its holdings in shares of Cencora by 3.8% during the fourth quarter. Nordea Investment Management AB now owns 1,256,356 shares of the company’s stock worth $426,715,000 after purchasing an additional 45,712 shares during the period. Finally, Assetmark Inc. raised its holdings in shares of Cencora by 57.0% during the fourth quarter. Assetmark Inc. now owns 67,281 shares of the company’s stock worth $22,724,000 after purchasing an additional 24,431 shares during the period. 97.52% of the stock is currently owned by institutional investors.

Cencora Stock Down 0.1%

COR stock opened at $281.22 on Wednesday. The company has a quick ratio of 0.59, a current ratio of 0.95 and a debt-to-equity ratio of 3.40. Cencora, Inc. has a fifty-two week low of $244.82 and a fifty-two week high of $377.54. The firm’s 50-day simple moving average is $287.49 and its 200 day simple moving average is $326.05. The stock has a market cap of $54.71 billion, a PE ratio of 21.57, a price-to-earnings-growth ratio of 1.52 and a beta of 0.59.

Cencora (NYSE:COR) last released its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a return on equity of 135.20% and a net margin of 0.78%.The firm had revenue of $78.36 billion during the quarter, compared to analyst estimates of $81.09 billion. During the same period last year, the business earned $4.42 EPS. The firm’s revenue was up 3.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, sell-side analysts predict that Cencora, Inc. will post 17.79 EPS for the current year.

Cencora announced that its board has authorized a share buyback program on Thursday, May 21st that permits the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization permits the company to buy up to 3.9% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company’s leadership believes its shares are undervalued.

Cencora Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were issued a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend was Friday, May 15th. Cencora’s dividend payout ratio (DPR) is 18.40%.

Analysts Set New Price Targets

A number of analysts have weighed in on the stock. Weiss Ratings cut shares of Cencora from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, May 22nd. UBS Group increased their target price on shares of Cencora from $410.00 to $412.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. William Blair assumed coverage on shares of Cencora in a report on Tuesday, April 28th. They set a “market perform” rating on the stock. Leerink Partners reissued an “outperform” rating on shares of Cencora in a report on Tuesday, March 17th. Finally, Wells Fargo & Company dropped their target price on shares of Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a report on Monday, May 11th. Twelve analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $374.00.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.